<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<title>DMseq</title>

<link href="style.css" rel="stylesheet" type="text/css" />
</head>

<body>
<div class="style3"></div><div class="style_2"><span class="style3"><a href="http://23.236.55.13" title="DMseq"><strong>DMseq</strong></a></span></div>
<div id="wrap">
<div id="topbar">
  <h1 id="sitename"><a href="http://23.236.55.13" target="_blank"> Â DMseq</a></h1>
  <div id="menus">
  <ul id="topmenu">
<li class="active"><a href="http://23.236.55.13">Home</a>
</li>
<li><a href="http://23.236.55.13/browser">Browser</a>
</li>
<li><a href="http://23.236.55.13:3838/dmseq-shinyapp">Splicing Data</a>
</li>
<li><a href="#">Plotting</a>
</li>
<li><a href="#">Contact</a>
</li>
</ul>
</div>
</div>


<div id="header">
</div>


<div id="content">
<div id="mainpage">
<h2>The Human Myotonic Dystrophy Transcriptome</h2>
<p>Myotonic dystrophy (DM) is a highly multi-systemic disorder caused by expanded CTG/CCTG repeats. Muscle weakness, myotonia, cardiac arrhythmia, and profound fatigue are common, yet exhibit extreme variability across affected individuals. Many transcriptome changes occur in DM, in particular changes in alternative splicing. Some of these changes are dependent on Muscleblind-like (MBNL) and Cugbp- and ETR3-like factors (CELF); however, numerous additional cellular pathways are perturbed, including dysregulation of transcription factors, microRNA processing, and protein signaling. To comprehensively assess transcriptome changes occurring in DM, and to evaluate the extent to which each of these pathways may contribute to disease pathogenesis, we performed RNAseq on a diverse panel of ~150 DM and normal biopsies/autopsies. Samples included biopsies from tibialis anterior and quadriceps, and autopsies from the heart and additional skeletal muscles across the body.<br/ >
<br />
Analyses of these data confirm previously observed correlations in mis-splicing and muscle weakness, and correlation in the extent of splicing dysregulation across multiple splicing events within a tissue, highlighting variability in molecular phenotypes across the patient population. These data suggest that DM1-mediated splicing dysregulation is more severe in distal relative to proximal muscles, and that distinct patterns of baseline alternative splicing patterns in these tissues may underlie these differences. Further analyses of these data should elucidate the contribution of MBNL depletion and CELF activation, among other pathways, to transcriptional dysregulation in DM. Additionally, this dataset provides a rich set of biomarkers that may be useful for monitoring therapeutic response.<br/ >
<br />
These data will be available to the broader scientific community through this publicly accessible website and database. We thank all contributors to this study, particularly those who have donated biological material.</p>
</div>
</div>


<div id="sidebarcontents"> 
<ul id="menu">
<li>
  <h2>Our Partners</h2>
</li>
<li>
	<ul>
		<li><a href="http://www.myotonic.org/">Myotonic Dystrophy Foundation</a></li>
		<li><a href="#">Website Link B</a></li>	 
		<li><a href="#">Website Link C</a></li>
		<li> <a href="#">Small Businesses Website</a></li>
		<li><a href="#">Flyer Website</a></li>
	</ul>
</li>
</ul>
</div>


</div>
<div id="footer">
<p>Copyright &copy; 2015 DMseq.org | <a href="#">Sitemap</a></p>
</div>

<div id="caption">
</div>

</body>
</html>
